YOU ARE HERE:
Latin America news
page  of 5
 
Headline
Date
  Brazil rejects tenofovir patent
05.09.08
  Immigration and prevention: the effect of migration on risk behaviour
15.08.08
  Treatment outcomes in Latin America, China and Botswana: successes and shortfalls
06.08.08
  World AIDS conference comes to Latin America
02.08.08
  High death rates in Peruvian patients defaulting from multi-drug-resistant tuberculosis treatment
12.06.08
  Anti-HIV treatment provided to 3 million in poorer countries by end of 2007
02.06.08
  Some HIV subtypes may carry natural resistance to tipranavir
20.03.08
  'Brazilian model' saves over $1 billion in anti-HIV treatment costs
20.11.07
  IAS: Roche admits long-standing low-level contamination of nelfinavir
26.07.07
  IAS: Regular dietician consultation effective at preventing HAART-associated dyslipidaemia
25.07.07
  IAS: Cardiovascular disease and diabetes increasing as causes of death for people with HIV in Brazil
25.07.07
  Brazil: Kaletra price cut agreed as generic efavirenz arrives
05.07.07
  Half of all new HIV infections could be averted if proven prevention efforts expanded
29.06.07
  Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated
21.06.07
  Near-global nelfinavir (Viracept) recall 'very difficult situation'
20.06.07
  WHO/UNAIDS endorse opt-out HIV testing
30.05.07
  Boehringer cuts nevirapine price for developing world
15.05.07
  Brazil issues compulsory license on efavirenz
07.05.07
  Brazil demands 60% efavirenz price cut, or may break patent
26.04.07
  Leprosy reported after starting HIV treatment, but it isn't a serious public health concern
08.02.07

page  of 5